AP Photo/Rogelio V. Solis A recent study of Meridia, or sibutramine hydrochloride, showed that it increases risks of heart attack or stroke in anyone who ...
Based on the serious nature of the review findings, FDA requested and the manufacturer agreed to add a new contraindication to the sibutramine drug label ...
Sibutramine, marketed as Meridia in the US and Europe, is a prescription weight loss drug that is essentially a combination of medications that increases ...
Instead, they contained sibutramine, which is sold as a weight loss drug under the name Meridia. Sibutramine is a controlled substance which shouldn't be ...
Last week, the EMEA advised doctors and pharmacists to stop prescribing and dispensing Meridia and other sibutramine medications including Ectiva, Reductil, ...
But those who used the appetite suppressant sibutramine (Meridia) did not -- in fact, in some cases, the blood pressure of people taking sibutramine went up ...
Now data from a study analyzing the effects of Meridia (sibutramine) on patients with existing cardiovascular health complications, suggests those initial ...
Lawyers and Settlements - Gordon Gibb - Jan 28, 2010
Washington, DC: The release of preliminary data from a six-year study on Meridia sibutramine hydrochloride has not only sparked debate over the diet drug ...
The risks of sibutramine, marketed as Meridia in Canada, outweigh its benefits, the European Medicines Agency said Thursday, after reviewing the drug's ...
Marketed as Meridia in the US, the sibutramine-based drug is sold in Europe as Reductil, Reduxade, and Zelium. The committee's recommendations must be ...
Email this story
